Rodolfo C.
- Country
- Italy
- Department
- Cardiology Unit
Research Overview
Data & Insights
Has run more than one trial at 0 of 1 partner site.
Specializations
Ischemic Heart Disease & Acute Coronary Syndromes
The investigator focuses on acute coronary syndrome, myocardial infarction, and outcomes after percutaneous coronary intervention.
- Acute coronary syndrome
- Acute myocardial infarction
- Chronic coronary syndrome in PCI
- Primary prevention of ASCVD
- Platelet inhibition strategies
Therapeutic strategies aim to reduce ischemic events and improve vascular health.
Heart Failure and Preserved Ejection Fraction
Research includes heart failure with reduced and preserved ejection fraction, obesity‑related phenotypes, and pulmonary hypertension.
- HFpEF or HFmrEF and obesity
- NT‑proBNP reduction in symptomatic HF
- Pulmonary hypertension with HFpEF
- Cardiac amyloid cardiomyopathy impact on HF
- FXIa inhibition in post‑stroke patients
Integrates cardiac imaging and hemodynamic assessment to guide therapy.
Hypertension and Vascular Risk Management
Investigations target uncontrolled and resistant hypertension, blood pressure control, and related organ damage.
- Uncontrolled and resistant hypertension
- Lorundrostat antihypertensive effect
- Blood pressure reduction in high‑risk patients
- Hypertension in chronic kidney disease
- Stroke prevention after non‑cardioembolic ischemic events
Focuses on novel agents and de‑escalation protocols to mitigate vascular risk.
Transthyretin Amyloidosis & Cardiomyopathy
The investigator studies transthyretin amyloid cardiomyopathy and related systemic amyloidosis.
- ATTR‑CM
- Hereditary transthyretin‑mediated amyloidosis
- Variant or wild‑type TTR amyloid cardiomyopathy
- Therapeutic impact of ALXN2220
- Cardiac outcomes in amyloid disease
Combines genetics, imaging, and disease‑modifying therapies.
Cardio‑Renal Metabolism & Chronic Kidney Disease
Work includes the interplay between chronic kidney disease, metabolic dysfunction, and cardiovascular outcomes.
- Chronic kidney disease
- IgA nephropathy
- Focal segmental glomerulosclerosis
- Proteinuria reduction strategies
- eGFR decline mitigation
Emphasizes integrated cardio‑renal therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.